Anti-inflammatory activity of macrolides: A new therapeutic potential?

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue SUPPL. B, 1998, Pages 37-46

  Labro, M T ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AZITHROMYCIN; CLARITHROMYCIN; CYTOKINE; ERYTHROMYCIN; ERYTHROMYCIN DERIVATIVE; JOSAMYCIN; MACROLIDE; MIDECAMYCIN; MIOKAMYCIN; ROKITAMYCIN; ROXITHROMYCIN; SPIRAMYCIN; TROLEANDOMYCIN;

APOPTOSIS; ASTHMA; BRONCHUS DISEASE; CHEMOTAXIS; CYTOKINE PRODUCTION; DRUG MECHANISM; EXPERIMENTAL MODEL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; INFLAMMATION; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; REVIEW;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CLINICAL TRIALS; HUMANS; MACROLIDES;

EID: 0031921423     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.suppl_2.37     Document Type: Review

References (86)

1. Fernandes, P. B. (1987). The macrolide revival: thirty five years after erythromycin. Antimicrobic Newsletter 4, 25-34.
2. Kirst, H. A. (1991). New macrolides: expanded horizons for an old class of antibiotics. Journal of Antimicrobial Chemotherapy 28, 787-90.
3. Bryskier, A. (1992). Newer macrolides and their potential target organisms. Current Opinion in Infectious Diseases 5, 764-72.
4. Labro, M. T. (1993). Intraphagocytic penetration of macrolide antibiotics. In Macrolides: Chemistry, Pharmacology and Clinical Uses (Bryskier, A., Butzler, J. P., Neu, H. C. & Tulkens, P. M., Eds), pp. 379-88. Arnette-Blackwell, Paris.
5. Bryskier, A. & Agouridas, C. (1994). Macrolide antibiotics and the heart. Expert Opinion in Investigational Drugs 3, 1213-9.
6. Bryskier, A., Agouridas, C. & Chantot, J. F. (1994). New medical targets for macrolides. Expert Opinion in Investigational Drugs 3, 405-10.
7. Labro, M. T. (1993). Effects of macrolides on host natural defenses. In Macrolides, Chemistry, Pharmacology and Clinical Uses (Bryskier, A., Butzler, J. P., Neu, H. C. & Tulkens, P. M., Eds), pp. 389-408. Arnette-Blackwell, Paris.
8. Labro, M. T. (1993). Immunomodulation by antibacterial agents. Is it clinically relevant? Drugs 45, 319-28.
9. Labro, M. T. (1993). Interactions between antimicrobial drugs and phagocytes: an overview. International journal of Antimicrobial Agents 3, 73-87.
10. Barrett, J. F. (1995). The immunomodulatory activities of antibacterials. Expert Opinion in Investigational Drugs 4, 551-7.
11. Mackenzie, A. H. (1983). Pharmacologic actions of 4-aminoquinoline compounds. American Journal of Medicine 75, Suppl. 1A, 5-10.
12. Caruso, I., Cazzola, M. & Santandrea, C. (1992). Clinical improvement in ankylosing spondylitis with rifamycin SV infiltrations of peripheral joints. Journal of International Medical Research 20, 171-81.
13. Tilley, B. C., Alarcon, G. S., Heyse, S. P., Trentham, D. E., Neuner, N., Kaplan, D. A. et al. (1995). Minocycline in rheumatoid arthritis. A 48-week, double-blind placebo-controlled trial. MIRA Trial Group. Annals of Internal Medicine 122, 81-9.
14. Baumann, H. & Gauldie, J. (1994). The acute phase response. Immunology Today 15, 74-80.
15. Hellewell, P. G. & Williams, P. J. (Eds) (1994). Immunopharmacology of Neutrophils. Academic Press, London.
16. Liles, W. C. & Van Voorkis, W. C. (1995). Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. Journal of Infectious Diseases 172, 1573-80.
17. Bates, E. J. (1995). Eicosanoids, fatty acids and neutrophils: their relevance to the pathophysiology of disease. Prostaglandins, Leukotrienes and Essential Fatty Acids 53, 75-86.
18. Lasky, L. A. (1995). Selectin-carbohydrate interactions and the initiation of the inflammatory response. Annual Review of Biochemistry 64, 113-39.
19. Itkin, I. H. & Menzel, M. L. (1970). The use of macrolide antibiotic substances in the treatment of asthma. Journal of Allergy 45, 146-62.
20. Spector, S. L., Katz, F. H. & Farr, R. S. (1974). Troleandomycin: effectiveness in steroid-dependent asthma and bronchitis. Journal of Allergy and Clinical Immunology 54, 367-79.
21. Plewig, G. & Schöpf, E. (1975). Anti-inflammatory effects of antimicrobial agents: an in vivo study. Journal of Investigative Dermatology 65, 532-6.
22. Miyatake, H., Taki, F., Taniguchi, H., Suzuki, R., Takagi, K. & Satake, T. (1991). Erythromycin reduces the severity of bronchial hyperesponsiveness in asthma. Chest 99, 670-3.
23. Suez, D. & Szefler, S. J. (1986). Excessive accumulation of mucus in children with asthma: a potential role for erythromycin? A case discussion. Journal of Allergy and Clinical Immunology 77, 330-4.
24. Tamaoki, J., Tagaya, E., Sakai, A. & Konno, K. (1995). Effects of macrolide antibiotics on neurally mediated contraction of human isolated bronchus. Journal of Allergy and Clinical Immunology 95, 853-9.
25. Goswami, S. K., Kivity, S. & Marom, Z. (1990). Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. American Review of Respiratory Disease 141, 72-8.
26. Tamaoki, J., Nakata, J., Tagaya, E. & Konno, K. (1996). Effects of roxithromycin and erythromycin on interleukin 8-induced neutrophil recruitment and goblet cell secretion in guinea pig tracheas. Antimicrobial Agents and Chemotherapy 40, 1726-8.
27. Khair, O. A., Devalia, J. L., Abdelaziz, M. M., Sapsford, R. J. & Davies, R. J. (1995). Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. European Respiratory Journal 8, 1451-7.
28. Homma, H. (1976). Definition of diffuse panbronchiolitis. Japanese Internal Medicine 65, 649-59.
29. Yamamoto, M., Kondo, A., Tamura, M., Izumi, R., Ina, Y. & Noda, M. (1990). Long-term therapeutic effects of erythromycin and new quinolone antibacterial agents on diffuse panbronchiolitis. Japanese Journal of Thoracic Diseases 28, 1305-13.
30. Kobayashi, H. (1995). Biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides. American Journal of Medicine 99, Suppl. 6A, 26S-30S.
31. Kobayashi, H. (1995). Airway biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides. Journal of Infective Chemotherapy 1, 1-15.
32. Ichikawa, Y., Ninomiya, H., Koga, H., Tanaka, M., Kinoshita, M., Tokunaga, N. et al. (1992). Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. American Review of Respiratory Disease 146, 196-203.
33. Kadota, J., Sakito, O., Kohno, S., Sawa, H., Mukae, H., Oda, H. et al. (1993). A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. American Review of Respiratory Disease 147, 153-9.
34. Oishi, K., Sonoda, F., Kobayashi, S., Iwagaki, A., Nagatake, T., Matsushima, K. et al. (1994). Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infection and Immunity 62, 4145-52.
35. Shirai, T., Sato, A. & Chida, K. (1995). Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity. Internal Medicine 34, 469-74.
36. Kobayashi, H., Shimada, K., Nakata, K. & Ootami, H. (1996). Study on azithromycin in treatment of diffuse panbronchiolitis. In Program and Abstracts of the Third International Conference on the Macrolides, Azalides and Streptogramins, Lisbon, 1996. Abstract 912, p. 75.
37. Kadota, J. (1996). Non-antibiotic effect of antibiotics. Clinical Microbiology and Infection 1, Suppl. 2, 20-2.
38. Sakito, O., Kadota, J., Kohno, S., Abe, K., Shirai, R. & Hara, K. (1996). Interleukin 1 beta, tumor necrosis factor alpha and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration 63, 42-8.
39. Nelson, S., Summer, W. R., Terry, P. B., Warr, G. A. & Jakab, G. J. (1987). Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung. American Review of Respiratory Disease 136, 1207-12.
40. Tamaoki, J., Sakai, N., Tagaya, E. & Konno, K. (1994). Macrolide antibiotics protect against endotoxin-induced vascular leakage and neutrophil accumulation in rat trachea. Antimicrobial Agents and Chemotherapy 38, 1641-3.
41. Mikasa, K., Kita, E., Sawaki, M., Kunimatsu, M., Hamada, K., Konishi, M. et al. (1992). The anti-inflammatory effect of erythromycin in zymosan-induced peritonitis of mice. Journal of Antimicrobial Chemotherapy 30, 339-48.
42. Tarayre, J. P., Aliaga, M., Barbara, M., Villanova, G., Ballester, R., Tisne-Versailles, J. et al. (1987). Cutaneously applied erythromycin base reduces various types of inflammatory reactions in mouse ear. International Journal of Tissue Reactions 9, 77-85.
43. Agen, C., Danesi, R., Blandizzi, C., Costa, M., Stacchini, B., Favini, P. et al. (1993). Macrolide antibiotics as anti-inflammatory agents: roxithromycin in an unexpected role. Agents and Actions 30, 85-90.
44. Scaglione, F. & Rossini, G. (1996). Comparative anti-inflammatory effect of roxithromycin, azithromycin and clarithromycin. In Program and Abstracts of the Third International Conference on the Macrolides, Azalides and Streptogramins, Lisbon, 1996. Abstract 904, p. 73.
45. Labro, M. T., Abdelghaffar, H. & Bryskier, A. (1995). Investigation of the mechanism underlying the stimulation of neutrophil exocytosis by macrolides. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract G39, p. 165. American Society for Microbiology, Washington, DC.
46. 2 by stimulated leucocytes. Journal of Antimicrobial Chemotherapy 14, 41-50.
47. Ras, G. J. & Anderson, R. (1986). An in-vitro study of oral therapeutic doses of co-trimoxazole and erythromycin stearate on abnormal polymorphonuclear leucocyte migration. Journal of Antimicrobial Chemotherapy 17, 185-93.
48. Torre, D., Broggini, M., Bottà, V., Sampietro, C., Busarello, R. & Garberi, C. (1991). In vitro and ex vivo effects of recent and new macrolide antibiotics on chemotaxis of human polymorphonuclear leukocytes. Journal of Chemotherapy 3, 236-9.
49. Labro, M. T., Bryskier, A., Babin-Chevaye, C. & Hakim, J. (1988). Interaction de la roxithromycine avec le polynucléaire neutrophile humain in-vitro et ex-vivo. Pathologie et Biologie 36, 711-4.
50. Labro, M. T., El Benna, J. & Barré, J. (1992). Effects of roxithromycin and erythromycin on human neutrophil functions ex-vivo. In Program and Abstracts of the 1st International Conference on the Macrolides, Azalides and Streptogramins, Santa Fe, 1992. Abstract 175.
51. Martin, R. R., Putman, M., Greenberg, S. B., Wallace, R. J. & Wilson, S. Z. (1980). Serial studies of leukocyte chemiluminescence: lack of effect of macrolide antibiotic therapy. Journal of Medicine 11, 39-48.
52. Wenisch, C., Parschalk, B., Zedtwitz-Liebenstein, K., Weihs, A., el Menyawi, I. & Graninger, W. (1996). Effect of single oral dose of azithromycin, clarithromycin and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry. Antimicrobial Agents and Chemotherapy 40, 2039-42.
53. Hirakata, Y., Kaku, M., Mizukane, R., Ishida, K., Furuya, N., Matsumoto, T. et al. (1992). Potential effects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 36, 1922-7.
54. Kita, E., Sawaki, M., Nishikawa, F., Mikasa, K., Yagyu, Y., Takeuchi, S. et al. (1990). Enhanced interleukin production after long-term administration of erythromycin stearate. Pharmacology 47, 177-83.
55. Kita, E., Sawaki, M., Mikasa, H., Hamada, H., Takeuchi, S., Maeda, K. et al. (1993). Alterations of host response by a long-term treatment of roxithromycin. Journal of Antimicrobial Chemotherapy 32, 285-94.
56. Konno, S., Adachi, M., Asano, K., Kawazoe, T., Okamoto, K. & Takahashi, T. (1992). Influence of roxithromycin on cell-mediated immune responses. Life Sciences 51, PL107-12.
57. Konno, S. Q., Adachi, K., Asano, K., Okamoto, F. & Takahashi, T. (1993). Anti-allergic activity of roxithromycin: inhibition of interleukin-5 production from mouse T-lymphocytes. Life Sciences 52, PL25-30.
58. Katahira, J., Haruki, K., Shibata, Y., Kibuchi, K., Hasegawa, H., Totuska, K. et al. (1991). Stimulation of interleukin-1 and tumor necrosis factor production by oral erythromycin. Chemotherapy (Tokyo) 39, 320-8.
59. Tomazic, J., Kotnik, V. & Wraber, B. (1993). In-vivo administration of azithromycin affects lymphocyte activities in vitro. Antimicrobial Agents and Chemotherapy 37, 1786-9.
60. Brennan, S., Sly, P. D., Everard, M. & Stewart, G. A. (1996). Anti-inflammatory actions of macrolides: potential for preventing lung damage in cystic fibrosis. In Program and Abstracts of the Third International Conference on the Macrolides, Azalides and Streptogramins, Lisbon, 1996. Abstract 910, p. 75.
61. Anderson, R. (1989). Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated Superoxide generation and autooxidation. Journal of Infectious Diseases 159, 966-73.
62. Labro, M. T., el Benna, J. & Babin-Chevaye, C. (1989). Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils. Journal of Antimicrobial Chemotherapy 24, 561-72.
63. Hand, W. L., Hand, D. L. & King-Thompson, N. L. (1990). Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes. Antimicrobial Agents and Chemotherapy 34, 863-70.
64. Jooné, G. K., Van Rensburg, C. E. & Anderson, R. (1992). Investigation of the in-vitro uptake, intraphagocytic biological activity and effects on neutrophil Superoxide generation of dirithromycin compared with erythromycin. Journal of Antimicrobial Chemotherapy 30, 509-23.
65. Labro, M. T., el Benna, J. & Abdelghaffar, H. (1993). Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin. Journal of Antimicrobial Chemotherapy 31, Suppl. C, 51-64.
66. Mitsuyama, T., Tanaka, T., Hidaka, K., Abe, M. & Hara, N. (1995). Inhibition by erythromycin of Superoxide anion production by human polymorphonuclear leukocytes through the action of cyclic AMP-dependent protein kinase. Respiration 62, 269-73.
67. Anderson, R., Theron, A. J. & Feldman, C. (1996). Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils. In Program and Abstracts of the Third International Conference on the Macrolides, Azalides and Streptogramins, Lisbon, 1996. Abstract 903, p. 73.
68. Feldman, C., Theron, A., Ramafi, G. & Anderson, R. (1996). Macrolides and azalides attenuate the effects of bioactive phospholipids on human ciliated epithelium in vitro. In Program and Abstracts of the Third International Conference on the Macrolides, Azalides and Streptogramins, Lisbon, 1996. Abstract 911, p. 75.
69. Perry, D. K., Hand, W. L., Edmondson, D. E. & Lambeth, J. D. (1992). Role of phospholipase D-derived diradylglycerol in the activation of the human neutrophil respiratory burst oxidase. Inhibition by phosphatidic acid phosphorylase inhibitors. Journal of Immunology 149, 2749-58.
70. Abdelghaffar, H., Mtairag, E. M. & Labro, M. T. (1994). Effects of dirithromycin and erythromycylamine on human neutrophil degranulation. Antimicrobial Agents and Chemotherapy 38, 1548-54.
71. Abdelghaffar, H., Vazifeh, D. & Labro, M. T. (1996). Comparison of various macrolides for stimulation of human neutrophil degranulation in vitro. Journal of Antimicrobial Chemotherapy 38, 81-93.
72. Labro, M. T., Abdelghaffar, H. & Mtairag, E. M. (1995). Interaction of macrolides with human neutrophils in vitro. In New Macrolides, Azalides and Streptogramins in Clinical Practice (Neu, H. C., Young, L. S., Zinner, S. H. & Acar, J. F., Eds), pp. 306-14. Marcel Dekker, New York.
73. Bailly, S., Pocidalo, J. J., Fay, M. & Gougerot-Pocidalo, M. A. (1991). Differential modulation of cytokine production by macrolides: interleukin-6 production is increased by spiramycin and erythromycin. Antimicrobial Agents and Chemotherapy 35, 2016-9.
74. Takizawa, H., Desaki, M., Ohtoshi, T., Kikutani, T., Okazaki, H., Sato, M. et al. (1995). Erythromycin suppresses interleukin-6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action. Biochemical and Biophysical Research Communications 210, 781-6.
75. 3-stimulated THP-1 cells. Antimicrobial Agents and Chemotherapy 40, 1548-51.
76. Morikawa, K., Oseko, F., Morikawa, S. & Iwamoto, K. (1994). Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin and clarithromycin on human T-lymphocyte function in vitro. Antimicrobial Agents and Chemotherapy 38, 2643-7.
77. Morikawa, K., Watabe, H., Araake, M. & Morikawa, S. (1996). Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrobial Agents and Chemotherapy 40, 1366-70.
78. lino, Y., Toriyama, M., Kudo, K., Natori, Y. & Yuo, A. (1992). Erythromycin inhibition of lipopolysaccharide-stimulated tumour necrosis factor alpha production by human monocytes in vitro. Annals of Otology, Rhinology, Laryngology, Suppl. 157, 16-20.
79. Takeshita, K., Yamagishi, I., Harada, M., Otomo, S., Nakagawa, T. & Mizushima, Y. (1989). Immunological and antiinflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages. Drugs under Experimental and Clinical Research 15, 527-33.
80. Tamaoki, J., Takeyama, K., Tagaya, E. & Konno, K. (1995). Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections. Antimicrobial Agents and Chemotherapy 39, 1688-90.
81. Nagai, M., Yamada, H., Nakada, S., Ochi, K., Nemoto, T. & Takahara, S. et al. (1995). A macrolide antibiotic, roxithromycin, inhibits the growth of human myeloid leukemia HL60 cells by producing multinucleate cells. Molecular and Cellular Biochemistry 144, 191-5.
82. Aoshiba, K., Nagai, A. & Konno, K. (1995). Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrobial Agents and Chemotherapy 39, 872-7.
83. Keicho, N., Kudoh, S., Yotsumoto, H. & Akagawa, K. S. (1994). Erythromycin promotes monocyte to macrophage differentiation. Journal of Antibiotics 47, 80-9.
84. Carbon, C. (1995). Clinical relevance of intracellular and extracellular concentrations of macrolides. Infection 23, Suppl. 1, S10-14.
85. Abdelghaffar, H. Vazifeh, D. & Labro, M. T. (1997). Erythromycin A-derived macrolides modify the functional activities of human neutrophils by altering the phospholipase D-phosphatidate phosphohydrolase transduction pathway. L-cladinose is involved both in alterations of neutrophil functions and modulation of this transductional pathway. Journal of Immunology 159, 3995-4005.
86. Moss, R. B. (1995). Cystic fibrosis: pathogenesis, pulmonary infection and treatment. Clinical Infectious Diseases 21, 839-51.